Moreover, the scores of genes related to the inhibitory regulation and exhaustion of T cells were also increased in IBC, and the molecules with increased expression levels included mainly FOXP3, CTLA4, and TIGIT, which also suggests that immunotherapy for IBC tumours needs to focus on other immune checkpoint molecules in addition to PD-L1 [43]. This evidence concerns the gene FOXP3 and neoplasm.